Skip to content

Elosulfase alfa

Vimizim (elosulfase alfa) is an enzyme pharmaceutical. Elosulfase alfa was first approved as Vimizim on 2014-02-14. It is used to treat mucopolysaccharidosis IV in the USA. It has been approved in Europe to treat mucopolysaccharidosis IV.
Trade Name Vimizim
Common Name Elosulfase alfa
Indication mucopolysaccharidosis iv
Drug Class Enzymes
Elosulfase alfa
Get full access now